日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparative Analysis of Maintenance Treatments in Patients with Newly Diagnosed Advanced Ovarian Cancer After First-Line Platinum-Based Regimens

一线铂类化疗后新诊断晚期卵巢癌患者维持治疗的比较分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17223714
Gasperoni, Lorenzo; Cancanelli, Luca; Ossato, Andrea; Del Bono, Luna; Vecchia, Stefano; Fontanella, Caterina; Damuzzo, Vera; Messori, Andrea
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled Trials

既往免疫检查点抑制剂和化疗失败后晚期非小细胞肺癌的治疗选择：五项随机对照试验的荟萃分析

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol32010046
Messori, Andrea; Ossato, Andrea; Gasperoni, Lorenzo; Del Bono, Luna; Inno, Alessandro; Damuzzo, Vera
Checkpoint
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Treatment of metastatic ALK-positive non-small cell lung cancer: indirect comparison of different ALK inhibitors using reconstructed patient data

转移性ALK阳性非小细胞肺癌的治疗：利用重建的患者数据对不同ALK抑制剂进行间接比较

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1566816
Damuzzo, Vera; Gasperoni, Lorenzo; Del Bono, Luna; Ossato, Andrea; Inno, Alessandro; Messori, Andrea
肺癌
肿瘤
肿瘤免疫
ALK
细胞生物学
发表日期：2025
文献求助 收藏

Rapid Desensitization to Antitumoral Agents. Result from a Retrospective Study, DESARCh

快速抗肿瘤药物脱敏：一项回顾性研究的结果，DESARCh

期刊:HOSPITAL PHARMACY
影响因子:0.7
doi:10.1177/00185787241278702
Tessari, Roberto; Ossato, Andrea; Realdon, Francesca; Montresor, Valentina; Giovagnoni, Giuseppe; Giannini, Michele; Gandini, Debora; Modena, Alessandra; Inno, Alessandro; Gori, Stefania
肿瘤免疫
肿瘤
ARC
发表日期：2025
文献求助 收藏

Efficacy of Immune Checkpoint Inhibitors vs. Tyrosine Kinase Inhibitors/Everolimus in Adjuvant Renal Cell Carcinoma: Indirect Comparison of Disease-Free Survival

免疫检查点抑制剂与酪氨酸激酶抑制剂/依维莫司在肾细胞癌辅助治疗中的疗效比较：无病生存期的间接比较

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16030557
Ossato, Andrea; Gasperoni, Lorenzo; Del Bono, Luna; Messori, Andrea; Damuzzo, Vera
Checkpoint
肿瘤
肿瘤免疫
信号转导
肾癌
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy?

局部晚期或转移性尿路上皮癌一线治疗方案的直接比较：化疗还有作用吗？

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16132400
Gasperoni, Lorenzo; Del Bono, Luna; Ossato, Andrea; Giunta, Emilio Francesco; Messori, Andrea; Damuzzo, Vera
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Case Report: Nephrocalcinosis in an infant due to vitamin-D food supplement overdose

病例报告：婴儿因维生素D食品补充剂过量引起的肾钙质沉着症

期刊:Frontiers in Pediatrics
影响因子:2
doi:10.3389/fped.2024.1485814
Pizzini, Carla; Ossato, Andrea; Realdon, Nicola; Tessari, Roberto
发表日期：2024
文献求助 收藏

Progression-Free and Overall Survival of First-Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination Regimens

晚期肾细胞癌一线治疗的无进展生存期和总生存期：六种联合治疗方案的间接比较

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15072029
Ossato, Andrea; Mengato, Daniele; Chiumente, Marco; Messori, Andrea; Damuzzo, Vera
细胞生物学
肿瘤
肿瘤免疫
肾癌
发表日期：2023
文献求助 收藏

Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses

应用 IPDfromKM-Shiny 方法比较针对同一种疾病的新疗法的疗效：14 项分析报告

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15061633
Messori, Andrea; Damuzzo, Vera; Rivano, Melania; Cancanelli, Luca; Di Spazio, Lorenzo; Ossato, Andrea; Chiumente, Marco; Mengato, Daniele
发表日期：2023
文献求助 收藏

Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient data

免疫检查点抑制剂作为晚期黑色素瘤的一线治疗：基于重建的个体患者数据评估无进展生存期

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.5067
Ossato, Andrea; Damuzzo, Vera; Baldo, Paolo; Mengato, Daniele; Chiumente, Marco; Messori, Andrea
黑色素瘤
免疫/内分泌
发表日期：2023
文献求助 收藏